Keshav Singh

Keshav Singh

Company: University of Alabama, Birmingham/Yuva Biosciences

Job title: Joy & Bill Harbert Endowed Chair & Professor/Scientific Founder & Chief Scientific Officer

Seminars:

Panel Discussion: Emerging Treatments for Chronic Diseases when Targeting Mitochondria– Therapeutic Avenues, Clinical Trials & Future Direction 4:00 pm

Examining the current treatment options and emerging targeted therapies How can the industry design novel therapeutic strategies for the treatment of chronic diseases when targeting mitochondria? Exploring clinical trial development and the continued impact of the pandemic on on-going clinical trialsRead more

day: Day Two

Panel Discussion: Evaluate the Current Challenges in Targeting-Mitochondria for Chronic Mitochondrial Diseases 4:30 pm

How can drug developers/research cut to the real barriers? Debate what is truly required to break through to successful treatments for mitochondrial diseases Understand how to make good disease models in which one can test potential therapeutic pathwaysRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.